98%
921
2 minutes
20
Objective: Although paradoxical insomnia is a prevalent subtype of chronic insomnia, the etiology of it is unclear. Contrary to complaints of little or no sleep, polysomnography (PSG) findings show that paradoxical insomnia patients have near normal sleep macrostructure. The purpose of this study is to determine the changes of microstructure and explore the etiology of paradoxical insomnia.
Methods: The PSG findings of 89 paradoxical insomnia patients were compared with those of 41 gender balanced healthy controls without sleep complaints. All subjects underwent nocturnal PSG recordings. Conventional PSG measures and microarousals were quantified and statistically analyzed. Receiver operating characteristic curve and correlation analysis were used to evaluate the potential of REM sleep microarousals and REM duration as indicators of paradoxical insomnia.
Results: Compared with the controls, paradoxical insomnia patients had no significant differences in sleep macrostructures. Statistical analysis showed that non-rapid eye movement (NREM) microarousals revealed no significant differences between paradoxical insomnia patients and controls. Noticeably, more spontaneous microarousals appeared in rapid eye movement (REM) stage for paradoxical insomnia patients. Based on receiver operating characteristic curve (ROC), the optimal cutoff value of REM sleep microarousals could predict paradoxical insomnia. Furthermore, a positive correlation between microarousals in REM sleep and the duration of REM sleep was presented in paradoxical insomnia patients.
Conclusions: The frequency of REM microarousals and the duration of REM sleep could reflect the real sleep state of paradoxical insomnia patients. That suggested PSG investigation extended to microarousal could be helpful to understand the etiology in paradoxical insomnia.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.sleep.2023.06.011 | DOI Listing |
Nihon Eiseigaku Zasshi
September 2025
Department of Hygiene, Public Health and Preventive Medicine, Showa Medical University School of Medicine, Tokyo, Japan.
Objective: In this study, we aimed to examine the relationship between the Eating Assessment Tool-10 (EAT10) score, a screening index for dysphagia, and the Epworth Sleepiness Scale (ESS) score, which evaluates daytime sleepiness in Japanese workers.
Method: A cross-sectional study of 496 workers (454 men and 42 women) at two business locations in Japan was conducted from November 2021 to June 2022. Dysphagia was assessed using the score of EAT10, a self-administered questionnaire.
Neuroscience
September 2025
Nanjing Research Institute of Electronic Technology, Nanjing 210039, China. Electronic address:
Sleep disorders encompass a range of diseases and symptoms that disrupt individual sleep patterns, degrade sleep quality, and diminish sleep efficiency. Currently, the mechanisms governing sleep regulation and the etiology of sleep disorders remain unclear, leading to clinical treatments that are primarily symptomatic due to the absence of precise intervention methods. Recent studies suggest that glymphatic-meningeal lymphatic route is responsible for the clearance of macromolecular metabolites from the brain, thus playing a pivotal role in maintaining sleep homeostasis and circadian rhythm.
View Article and Find Full Text PDFSleep Med Clin
September 2025
Parkinson Foundation Centre of Excellence, King's College Hospital and King's College, London, United Kingdom; King's College Hospital, London, Dubai, UAE; Institute of Psychiatry, Psychology and Neuroscience, King's College, Dementech Clinical Neuroscience Centre London, United Kingdom. Electronic
Sleep dysfunction can affect almost 90% of Parkinson's disease (PD) patients and insomnia related to fragmented sleep is common. Satisfactory management remains an unmet need although dopaminergic non-oral treatments utilising a continuous drug delivery strategy appears to help sleep maintenance insomnia. Transdermal therapy with rotigotine or subcutaneous apomorphine infusion is effective while recent data show considerable efficacy of intrajejunal or subcutaneous levodopa infusion on alleviation of insomnia in PD.
View Article and Find Full Text PDFSleep Med Clin
September 2025
Sleep Research Institute, Calle Padre Damián, Madrid, Spain; Instituto Europeo del Sueño, Panama. Electronic address:
Restless legs syndrome (RLS) frequently coexists with Parkinson's disease (PD), significantly contributing to sleep disturbances and reduced quality of life. This review examines the prevalence, clinical features, pathophysiology, and treatment of RLS in patients with PD. Although prevalence estimates vary due to differences in diagnostic criteria and assessment methods, RLS is consistently linked to a greater burden of nonmotor symptoms, including sleep disruption, depression, and cognitive impairment, which further complicate disease management.
View Article and Find Full Text PDFSleep Med Clin
September 2025
Department of Neurology, County Clinic Hospital, Calea Bucuresti 25-27 Street, 500037 Brasov; Faculty of Medicine, Transilvania University, Balcescu Street 56, 500040 Brasov, Romania.
Shifting away from the traditional perspective on parkisonism, which focused only on the motor state of the patients, recent research proves the importance of early recognition and treatment of non-motor symptoms. Patients with parkinsonism, who suffer from various sleep disturbances, such as excessive daytime sleepiness (EDS), experience lower quality of life, a negative impact on activities of daily living, and possible exposure to life-threatening situations. Implementing the routine use of subjective and objective means of diagnosing EDS, into clinical practice, allows for a personalised management plan, in scope of efficiently decreasing disease burden for both the patient and the caregiver.
View Article and Find Full Text PDF